Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis

• मुख्य लेखकों: Micah Silaba, MMed (लेखक), Michael Ooko, MSc (लेखक), Christian Bottomley, PhD (लेखक), Joyce Sande, MMed (लेखक), Rachel Benamore, FRCR (लेखक), Kate Park, FRCR (लेखक), James Ignas, MD (लेखक), Kathryn Maitland, FMedSci (लेखक), Neema Mturi, MMed (लेखक), Anne Makumi, MSc (लेखक), Mark Otiende, MSc (लेखक), Stanley Kagwanja, Dip MIS (लेखक), Sylvester Safari, Dip MIS (लेखक), Victor Ochola, BSc (लेखक), Tahreni Bwanaali, MBA (लेखक), Evasius Bauni, PhD (लेखक), Fergus Gleeson, FRCR (लेखक), Maria Deloria Knoll, PhD (लेखक), Ifedayo Adetifa, PhD (लेखक), Kevin Marsh, FMedSci (लेखक), Thomas N Williams, FMedSci (लेखक), Tatu Kamau, MPH (लेखक), Shahnaaz Sharif, MD (लेखक), Orin S Levine, PhD (लेखक), Laura L Hammitt, MD (लेखक), J Anthony G Scott, FMedSci (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2019-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Summary: Background: Pneumococcal conjugate vaccines (PCV) are highly protective against invasive pneumococcal disease caused by vaccine serotypes, but the burden of pneumococcal disease in low-income and middle-income countries is dominated by pneumonia, most of which is non-bacteraemic. We examine...